Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro

24 May 2024

Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro.

Need Help?

Please use the contact form to get support. Thank you.